These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months
Corcept Therapeutics and Anika Therapeutics received Wall Street support after reporting strong second-quarter results and sharply raising their full-year 2026 outlook. H.C. Wainwright raised CORT’s price target to $165 from $95 and maintained a ‘Buy’ rating, according to The Fly. Corcept reported second-quarter revenue of $256.1 million, up 32% year over year. B. Riley raised … Read more